Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.
Stephan LobitzClaudia FrömmelAnnemarie BroseOliver BlankensteinCharles TurnerR Neil DaltonYvonne DanielJeannette KleinPublished in: Annals of hematology (2022)
Keyphrases
- sickle cell disease
- tandem mass spectrometry
- ultra high performance liquid chromatography
- high performance liquid chromatography
- liquid chromatography
- gas chromatography
- simultaneous determination
- high resolution
- randomized controlled trial
- solid phase extraction
- high resolution mass spectrometry
- mass spectrometry
- replacement therapy